
معرفی
Associate Professor Marie-Odile Parat is a prominent researcher and educator at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland. With a career spanning over two decades in cancer research, pharmacology, and molecular biology, she has established herself as a leading expert in opioid-cancer interactions and caveolae biology.
Dr. Parat earned her Pharm.D. from University Joseph Fourier in Grenoble, France, a Masters in Cutaneous Biology from University Claude Bernard in Lyon, France, and her Ph.D. in Cell Biology from University Joseph Fourier in Grenoble, France. She further holds postgraduate diplomas in Biomedical and Industrial Pharmacy, Photobiology, Pharmaceutical Management, and Public Health. Her professional journey includes a Pharmaceutical Residency at University Hospitals of Grenoble, research at Estee Lauder's R&D laboratories, and three years with the United Nations International Trade Center in Geneva, Switzerland.
Her research focuses on the relationship between opioids and cancer progression, particularly how perioperative pain management influences cancer recurrence and metastasis. She also investigates caveolae biology and their role in cell migration, angiogenesis, and cancer progression. Her work spans from basic science to translational research, with the goal of developing novel cancer therapies.
Dr. Parat's publication record demonstrates strong focus on cancer biology, opioid pharmacology, and drug delivery systems. Recent work includes systematic reviews on opioid-cancer relationships, novel drug delivery systems for gynecological conditions, and molecular mechanisms of cancer metastasis across multiple high-impact journals in oncology, pharmacology, and molecular biology.
She has received research funding from prestigious organizations including the Research Funding Agency of the State of São Paulo (FAPESP), the American Heart Association, the American Cancer Society, the National Heart Foundation of Australia, Cancer Council Queensland, and the Australian Research Council (ARC).
As an educator, Dr. Parat has supervised numerous PhD students whose research spans cancer biology, drug delivery systems, and natural product pharmacology. Her current research program includes investigations into opioid receptor-active metabolites produced by the human gut microbiome, tumor-targeted gene delivery platforms, and novel drug delivery systems for gynecological conditions.





